Reviewing of term sheet for licensing technology for Aptimmune Biologics

November 11, 2019

 

 

Collyer Law advised Aptimmune Biologics, Inc, a US based company which specializes in developing revolutionary mucosal vaccines, made with Barricade (TM) Formulation Technology, in connection with reviewing of term sheet for licensing technology.

Share on Facebook
Share on Twitter
Please reload

Featured Posts

The International A-List 2020: Top 100 India-focused lawyers

March 27, 2020

1/10
Please reload

Recent Posts

August 14, 2020

Please reload

Archive
Please reload

Search By Tags